Medicare Pharm Ltd in Croydon, CR0 2LX

Description

Data updated on: 01-11-2023

This company referred to as Medicare Pharm was founded on 2010-06-16 as a Private Limited Company. The firm's registered office can be found at Croydon on 6th Floor, Amp House, Dingwall Road. When you want to reach the firm by post, its area code is CR0 2LX. The office registration number for Medicare Pharm Ltd is 07286449. The firm's SIC and NACE codes are 47730 and their NACE code stands for Dispensing chemist in specialised stores. The latest accounts were submitted for the period up to Thu, 30th Jun 2022 and the most current annual confirmation statement was submitted on Thu, 10th Aug 2023.

On 2018-04-16, the enterprise was looking for a pharmacy sales assistant to fill a full time post in the medical industry in London, London. They offered a fixed term contract. The offered job position required entry level employee experience and a GCSE. While sending your application include reference id SE9 6UD.

Presently, the limited company is managed by 1 director: Ayodele M., who was selected to lead the company in June 2010.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30
Currency
Net Worth	2 982	20 981	36 758	45 042	54 268	33 833	45 404

Balance Sheet
Cash Bank On Hand							5 334	6 619	3 560	8 524	63 473	162 022	94 463
Current Assets	65 710	108 481	120 060	110 077	102 090	93 455	124 209	168 568	183 282	252 971	303 558	353 832	345 972
Debtors	23 710	73 266	78 804	58 557	58 811	68 078	73 467	91 949	87 722	154 747	155 085	114 810	114 509
Net Assets Liabilities							38 019	42 857	60 737	87 130	125 169	192 847	232 150
Other Debtors							6 086	24 680
Property Plant Equipment							27 788	870 341	865 790	861 993	858 417	867 746	863 972
Total Inventories							25 000	50 500	92 000	89 700	85 000	77 000	137 000
Cash Bank In Hand	22 000	20 215	24 255	32 520	18 754	6 187
Intangible Fixed Assets	206 500	196 175	185 850	175 525	165 200	154 875
Net Assets Liabilities Including Pension Asset Liability	2 982	20 981	36 758	45 042	54 268	33 833	45 404
Stocks Inventory	20 000	10 000	17 000	19 000	24 525	20 000
Tangible Fixed Assets	269 333	249 500	227 661	19 107	43 031	34 545

Capital & Reserves
Called Up Share Capital	2	2	2	2	2	2
Profit Loss Account Reserve	2 980	15 979	36 756	45 040	54 266	33 831
Shareholder Funds	2 982	20 981	36 758	45 042	54 268	33 833	45 404

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets							61 950	72 275	82 600	92 925	103 250	113 575	123 900
Accumulated Depreciation Impairment Property Plant Equipment							62 117	69 222	75 695	81 122	85 583	93 254	99 707
Amortisation Rate Used For Intangible Assets								5	5	5	5	5	5
Average Number Employees During Period							4	13	12	11	11	13	9
Bank Borrowings Overdrafts							127 336
Comprehensive Income Expense							9 186	6 838
Corporation Tax Payable							17 496	11 974
Creditors							110 784	355 147	379 834	416 554	461 577	497 692	491 822
Depreciation Rate Used For Property Plant Equipment								20	20	20	20	20	20
Dividends Paid							5 000	2 000
Fixed Assets	475 833	445 675	413 511	194 632	211 299	189 420	172 338	1 004 566	989 690	975 568	961 667	960 671	946 572
Income Expense Recognised Directly In Equity							-5 000	-2 000
Increase From Amortisation Charge For Year Intangible Assets								10 325	10 325	10 325	10 325	10 325	10 325
Increase From Depreciation Charge For Year Property Plant Equipment								7 105	6 473	5 427	4 461	7 671	6 453
Intangible Assets							144 550	134 225	123 900	113 575	103 250	92 925	82 600
Intangible Assets Gross Cost							206 500	206 500	206 500	206 500	206 500	206 500	206 500
Net Current Assets Liabilities	22 585	32 425	38 080	33 073	11 750	1 879	-9 411	-206 080	-222 052	-163 583	-158 019	-137 624	-145 850
Other Creditors							32 903	199 968
Other Taxation Social Security Payable							74	1 348
Profit Loss							9 186	6 838
Property Plant Equipment Gross Cost							89 905	939 563	941 485	943 115	943 999	961 000	963 679
Total Additions Including From Business Combinations Property Plant Equipment									1 922	1 630	885	17 001	2 679
Total Assets Less Current Liabilities	498 516	483 100	451 592	227 705	224 981	191 299	162 927	798 486	788 294	811 985	803 648	823 047	800 722
Trade Creditors Trade Payables							60 311	141 857
Trade Debtors Trade Receivables							67 381	67 269
Advances Credits Directors						11 898	28 053	199 818	309 639	326 613	324 606	296 378	254 763
Advances Credits Made In Period Directors							16 155	241 572	40 014	16 974	2 007	28 228
Accruals Deferred Income						567	150
Called Up Share Capital Not Paid Not Expressed As Current Asset	98	98
Creditors Due After One Year	495 444	462 119	414 833	182 663	170 713	157 466	117 373
Creditors Due Within One Year	43 125	71 056	81 979	77 004	90 340	92 386	134 003
Instalment Debts Due After5 Years			39 486	16 827
Intangible Fixed Assets Aggregate Amortisation Impairment	3 500	10 325	20 650	30 975	41 300	51 625
Intangible Fixed Assets Amortisation Charged In Period		10 325	10 325	10 325	10 325	10 325
Intangible Fixed Assets Cost Or Valuation	210 000	206 500	206 500	206 500	206 500	206 500
Number Shares Allotted					2	2
Other Debtors Due After One Year			78 804	58 557
Par Value Share					1	1
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal						810	383
Provisions For Liabilities Charges	90	98
Secured Debts		462 119	414 834	165 836
Share Capital Allotted Called Up Paid				2	2	2
Tangible Fixed Assets Additions		7 001	5 882		38 516	150
Tangible Fixed Assets Cost Or Valuation	277 500	284 501	282 216	54 883	93 399	89 715
Tangible Fixed Assets Depreciation	8 167	26 834	54 555	35 776	46 534	55 170
Tangible Fixed Assets Depreciation Charged In Period		26 834	27 721	12 221	11 524	8 636
Tangible Fixed Assets Depreciation Decrease Increase On Disposals				31 000
Tangible Fixed Assets Disposals				227 333

Company staff

Ayodele M.

Role: Director

Appointed: 16 June 2010

Latest update: 13 April 2024

People with significant control

Ayodele Ajibike M. is the individual with significant control over this firm, owns over 3/4 of company shares.

Ayodele Ajibike M.

Notified on 1 August 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	31 March 2024
Account last made up date	30 June 2022
Confirmation statement next due date	24 August 2024
Confirmation statement last made up date	10 August 2023

Annual Accounts 27 March 2013
Start Date For Period Covered By Report	2011-07-01
End Date For Period Covered By Report	2012-06-30
Date Approval Accounts	27 March 2013
Annual Accounts 29 November 2013
Start Date For Period Covered By Report	2012-07-01
End Date For Period Covered By Report	2013-06-30
Date Approval Accounts	29 November 2013
Annual Accounts 24 March 2015
Start Date For Period Covered By Report	2013-07-01
End Date For Period Covered By Report	2014-06-30
Date Approval Accounts	24 March 2015
Annual Accounts 30 March 2016
Start Date For Period Covered By Report	2014-07-01
End Date For Period Covered By Report	2015-06-30
Date Approval Accounts	30 March 2016
Annual Accounts 31 March 2017
Start Date For Period Covered By Report	2015-07-01
End Date For Period Covered By Report	2016-06-30
Date Approval Accounts	31 March 2017
Annual Accounts 28 March 2018
Start Date For Period Covered By Report	2016-07-01
End Date For Period Covered By Report	2017-06-30
Date Approval Accounts	28 March 2018
Annual Accounts
Start Date For Period Covered By Report	2017-07-01
End Date For Period Covered By Report	30/06/2018
Annual Accounts
Start Date For Period Covered By Report	2018-07-01
End Date For Period Covered By Report	30/06/2019
Annual Accounts
Start Date For Period Covered By Report	2019-07-01
End Date For Period Covered By Report	30/06/2020
Annual Accounts
Start Date For Period Covered By Report	2020-07-01
End Date For Period Covered By Report	30/06/2021
Annual Accounts
Start Date For Period Covered By Report	2021-07-01
End Date For Period Covered By Report	30/06/2022
Annual Accounts
Start Date For Period Covered By Report	01/07/2022
End Date For Period Covered By Report	30/06/2023

pharmacy sales assistant in London, posted on Monday 16th April 2018
Region / City	London, London
Industry	Medical services and healthcare
Work hours	Fixed term contract
Job type	full time
Career level	entry level employees
Education level	a GCSE (Scottish or equivalent)
Job reference code	SE9 6UD

Medicare Pharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Ayodele M.

People with significant control

Ayodele Ajibike M.

Accounts Documents

Jobs and Vacancies at Medicare Pharm Limited

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies